# A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas

> **NCT01007591** · PHASE3 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 40 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** LEO 80190
- **DRUG:** Hydrocortisone

## Key facts

- **NCT ID:** NCT01007591
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-06
- **Final completion:** 2010-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01007591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01007591, "A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01007591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*